Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tissue Quality of Integra vs. BTM Treated Burns
Sponsor: Integra LifeSciences Corporation
Summary
An observational analysis of Integra-treated burns and Novosorb Biodegradable Temporizing Matrix (BTM)-treated burns will be undertaken 12-36 months post final skin graft application by retrospectively analyzing the patient's electronic medical record, and prospectively using a non-invasive measures of tissue quality and patient-reported outcomes. Patients will be offered the option to consent for a tissue biopsy for pathological evaluation.
Official title: An Observational Cohort Analysis of Tissue Quality of Integra Dermal Matrix (Integra®)-Treated Burns and NovoSorb® Biodegradable Temporizing Matrix (BTM)-Treated Burns 12-36 Months Post Final Skin Graft Application
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
OBSERVATIONAL
Enrollment
0
Start Date
2025-03-01
Completion Date
2025-09-30
Last Updated
2026-09-21
Healthy Volunteers
No